Skip to main content
. 2021 Jun 26;14:101–103. doi: 10.1016/j.jdcr.2021.06.013

Fig 3.

Fig 3

No evidence of recurrence of squamous cell carcinoma 3 months after a 5-day course of topical tirbanibulin 1% ointment.